The Agreement on Reciprocal Trade grants more than 99 percent of U.S. products—including pharmaceuticals and medical devices—zero-tariff access to the Indonesian market. The agreement goes further, removing many non-tariff barriers as well. Most significantly, Indonesia now recognizes FDA certifications and prior market authorizations for U.S.-made medical devices. To subscribe please click here
